TELMIKIND AM 80

About

Telmikind AM 80 is a potent combination antihypertensive medication containing Telmisartan 80mg, an angiotensin II receptor blocker (ARB), and Amlodipine, a dihydropyridine calcium channel blocker (CCB). Telmisartan, at this higher dose, provides enhanced blockade of the AT1 receptor, effectively preventing angiotensin II from mediating vasoconstriction and aldosterone release. This leads to significant systemic vasodilation and a reduction in blood pressure. Amlodipine complements this action by relaxing vascular smooth muscle through the inhibition of calcium ion influx, primarily affecting peripheral arterioles and causing vasodilation, which further decreases peripheral vascular resistance. This dual mechanism of action provides effective and sustained blood pressure control, particularly beneficial for patients whose hypertension is not adequately managed by monotherapy or lower-dose combinations. The combination is also advantageous for patients who may have co-existing conditions like angina, as Amlodipine is effective in managing such symptoms.

Uses

• Treatment of essential hypertension.
• When blood pressure is inadequately controlled by monotherapy.
• To reduce the risk of cardiovascular morbidity and mortality.
• Long-term management of high blood pressure.

Directions For Use

Take one tablet orally once daily, with or without food, at the same time each day, or as prescribed by your doctor.

Benefits

• Potent and sustained blood pressure reduction.
• Synergistic action of two distinct antihypertensive classes.
• Convenient once-daily dosing.
• Improved patient compliance compared to multiple pills.
• Effective for patients with co-existing angina.
• Reduces the risk of cardiovascular events.

Side Effects

• Dizziness or lightheadedness
• Headache
• Fatigue
• Peripheral edema (swelling of ankles/feet)
• Nausea or abdominal discomfort
• Flushing
• Palpitations
• Hypotension
• Cough (less common than ACE inhibitors)
• Muscle cramps
• Orthostatic hypotension
• Gastrointestinal upset

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can enhance the blood pressure-lowering effect and increase the risk of dizziness or fainting.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to potential fetal harm and toxicity from Telmisartan.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and could harm the infant. Consult a doctor.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary, and liver function should be monitored.
• Kidney - Use with caution in patients with severe renal impairment; regular monitoring of kidney function is essential.
• Lung - Generally safe, but patients with severe hypotension may experience secondary respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.